The ClearCell® FX1 System is a fully automated device for cell retrieval that can separate and enrich wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood.

It is driven by our CTChip®FR1 biochip, which is a single-use microfluidic biochip.

A blood sample is obtained from a patient through a simple blood draw. We first chemically treat the blood sample to lyse (break down) and remove the red blood cells. The sample is then passed through the CTChip® FR1 biochip to isolate the CTCs from leukocytes (white blood cells).

Our ClearCell® FX1 System has been tested and validated for use with human blood samples. The choice of blood collection tube depends on the intended downstream application, or diagnostic test. Our recommenced blood collection tubes to use with the ClearCell® FX1 System includes the Streck Cell-free DNA BCT® and EDTA tubes.

For more information, visit Biolidics.com.